Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9368439 | 0.90 | DRD2 (0.54) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL9367707 | 0.85 | DRD2 (0.51) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL9370055 | 0.84 | DRD2 (0.49) | DRD2HTR2CHTR2ADRD4 | |
| SCHEMBL9367686 | 0.82 | — | — | |
| SCHEMBL7783724 | 0.77 | DRD2 (0.54) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL9367665 | 0.76 | HTR2C (0.53) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL13648727 | 0.75 | DRD2 (0.62) | DRD2HTR2CHTR2ADRD3ALDH1A1 | |
| SCHEMBL9371451 | 0.74 | DRD2 (0.56) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL9367275 | 0.73 | DRD2 (0.55) | DRD2HTR2CHTR2ADRD3DRD4 | |
| SCHEMBL9368460 | 0.73 | DRD3 (0.50) | DRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431579-B1 | Substituted cyclohexenes as central nervous system agents | WARNER LAMBERT CO (US) | 1994-07-27 | — | — | EP | claimed |
| EP-0431579-A2 | Substituted cyclohexenes as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | claimed |
| EP-0431579-B1 | Substituted cyclohexenes as central nervous system agents | WARNER LAMBERT CO (US) | 1994-07-27 | — | — | EP | disclosed |
| EP-0431579-A2 | Substituted cyclohexenes as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4975445-A | Antidepressants | WARNER-LAMBERT COMPANY (US) | 1990-12-04 | — | — | US | disclosed |